IndiaCatalog.com
India News
Search Web Directory
News Home
Pharma shares in focus as Nifty Pharma index rises 2%
Posted on 8th June 2018
Shares of pharmaceutical companies were in focus in otherwise subdued market with Nifty Pharma index surging more than 2%, and extending its gains in the past two days on the National Stock Exchange (NSE).

Sun Pharmaceutical Industries, Cadila Healthcare, Dr Reddy’s Laboratories, Cipla, Glenmark Pharmaceuticals and Lupin from the Nifty Pharma index were up in the range of 2% to 3% on the NSE.

Caplin Point Laboratories, Ipca Laboratories, RPG Life Sciences, Sun Pharma Advanced Research (SPARC) and Strides Shasun were up between 3% and 10% on the BSE.

At 09:49 am; Nifty Pharma index, the largest gainer among sectoral indices, was up 2.3% as compared to 0.3% decline in the Nifty 50 index. In past three trading sessions, pharma index was up 4% against 1.4% rise in the benchmark index.

Sun Pharma, the largest gainer among Nifty Pharma index, was up 3.4% to Rs 506 on the NSE. In past two weeks, the stock gained 8% after the after the drug maker reported a better than expected EBITDA (earnings before interest, tax, depreciation and amortisation) margin at 21.1% in March quarter (Q4FY18).

“Management explained that the final date for completion of remediation activities in the submitted CAPA is 2QFY19E. This helps us believe that management has baked in supplies from Halol in 2HFY19 post anticipated resolution. EIR for the plant can be expected anywhere between Jun’18 to Sep’18. Also, the management alluded that the supplies from Halol have improved over previous two quarters,” analysts at Dolat Capital Markets said in result update with ‘buy’ rating on the stock and 12 month target price of Rs 750 per share.

We believe that successful Halol resolution to drive good approvals. The specialty basket to scale up with additional costs going ahead, however this would be next growth engine for the company, the brokerage firm said in a report.

Related Companies: National Stock Exchange of India Ltd (NSE)    

Other Latest News
Bharti Airtel defers Q2 results till Nov 14 over ambiguity on AGR verdict
Posted on 29th October 2019

Bharti Airtel said on Tuesday it has postponed its second-quarter earnings report to mid-November, as the wireless operator sought clarity on the court ruling asking telecom firms to cough up overdue payments to the government.

Shares of the company, which was expected to release its quarterly numbers later in the day, dropped 3.3 per cent in early trade.


Rupee slips 8 paise vs US dollar in early trade amid drop in oil prices
Posted on 7th October 2019
The rupee on Monday opened eight paise lower at 70.96 against the US dollar amid drop in crude oil prices and rise in Asian equities. The domestic unit on Friday closed almost flat at 70.88 against after the Reserve Bank of India (RBI) in a widely expected move cut key interest rates by 0.25 percentage point.

On a weekly basis, the local unit slumped by 32 paise.


LIC pips private insurers in first-year premium growth during April-August
Posted on 13th September 2019
In the first five months of the current financial year, first-year premiums of life insurance companies grew by 39.84% (year-on-year) at Rs 1.05 lakh crore as compared to Rs 75,588.35 crore in April-August of 2018-19.

Life Insurance Corporation of India (LIC) continued to grow at a faster pace compared to private insurance players, shows the data from the Insurance Regulatory and Development Authority of India (Irdai).


Apollo Hospitals rules out further stake sale
Posted on 13th September 2019
Apollo Hospitals Enterprise (AHEL) has ruled out further dilution of promoters’ stake in the company. The company also said its Rs 1,337-crore stake sale of Apollo Munich Health Insurance with mortgage major HDFC will be concluded by October. Following these stake sales, the promoters’ pledged position will come down from a high of 76% to 54% by October and eventually to 20% by November or December, company sources said here.

World trusts India on Kashmir, not us: Pakistan minister Ijaz Ahmed Shah
Posted on 13th September 2019
In a major embarrassment for Pakistan and its Prime Minister Imran Khan, the country's Interior Minister Ijaz Ahmed Shah, a retired brigadier, said the international community didn't believe Pakistan's narrative on Kashmir; instead it is India whose version is trusted.

» Post a FREE Classified Advertisement
Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.
Jobs in India India Real Estate Automobiles Matrimonials Beauty & Fitness

Add a comment for Pharma shares in focus as Nifty Pharma index rises 2%
Please only use this form to enter comments on the above company. All comments are reviewed before they are displayed on the web site. Not all comments may be displayed. Check back with us to see if your comments have been displayed.
If you want us to email the comments posted by users, please Subscribe by email
Name*
Comments*
Security Code*
 

Be the first person to write a business review for Pharma shares in focus as Nifty Pharma index rises 2%

Most Read News

More India News

Photo Gallery

Delhi(11 Images) Delhi City
Hebah Patel(10 Images) Hebah Patel
  India Web Directory
Business Profiles
Yellow Pages
Photo Galleries
Global Web Directory
*** FREE India Classifieds
Order Premium Listings
Submit a Site
Business Reviews
Home
About us
Link to us
Advertise
Contact us
Google Search Keywords: India Catalog, IndiaCatalog, India Web Directory
    © 1999 - 2026 IndiaCatalog.com
    All Rights Reserved
Privacy Statement